Long-term clinical effect of Tangyiping Granules (糖异平颗粒) on patients with impaired glucose tolerance
- 76 Downloads
To evaluate the long-term clinical effect of Tangyiping Granules (糖异平颗粒, TYP) on patients with impaired glucose tolerance (IGT) to achieve normal glucose tolerance (NGT) and hence preventing them from conversion to diabetes mellitus (DM).
In total, 127 participants with IGT were randomly assigned to the control (63 cases, 3 lost to follow-up) and treatment groups (64 cases, 4 lost to follow-up) according to the random number table. The control group received lifestyle intervention alone, while the patients in the treatment group took orally 10 g of TYP twice daily in addition to lifestyle intervention for 12 weeks. The rates of patients achieving NGT or experiencing conversion to DM as main outcome measure were observed at 3, 12, and 24 months after TYP treatment. The secondary outcome measures included fasting plasma glucose (FPG), 2-h postprandial plasma glucose (2hPG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), 2-h insulin (2hINS), homeostatic model assessment of insulin resistance (HOMA-IR), blood lipid and patients' complains of Chinese medicine (CM) symptoms before and after treatment.
A higher proportion of the treatment group achieved NGT compared with the control group after 3-, 12- and 24-month follow-up (75.00% vs. 43.33%, 58.33% vs. 35.00%, 46.67% vs. 26.67%, respectively, P<0.05). The IGT to DM conversion rate of the treatment group was significantly lower than that of the control group at the end of 24-month follow-up (16.67% vs. 31.67%, P<0.05). Before treatment, FPG, 2hPG, HbA1c, FINS, 2hINS, HOMA-IR, triglyceride (TG), total cholesterol, low- and high-density lipoprotein cholesterol levels had no statistical difference between the two groups (P>0.05). After treatment, the 2hPG, HbA1c, HOMA-IR, and TG levels of the treatment group decreased significantly compared with those of the control group (P<0.05). CM symptoms such as exhaustion, irritability, chest tightness and breathless, spontaneous sweating, constipation, and dark thick and greasy tongue were significantly improved in the treatment group as compared with the control group (P<0.05). No severe adverse events occurred.
TYP administered at the IGT stage with a disciplined lifestyle delayed IGT developing into type 2 DM.
KeywordsTangyiping Granules conversion of impaired glucose tolerance long-term clinical effect Chinese medicine
Unable to display preview. Download preview PDF.
- 3.Xiang HD, Wu W, Liu CQ, Li K, Feng JG, Zhang YT, et al. The 1996 national diabetes epidemiological features of the baseline survey report. Chin Diabetes (Chin) 1998;6:131–133.Google Scholar
- 5.Rosettenstein K, Viecelli A, Yong K, Nguyen HD, Chakera A, Chan D, et al. Diagnostic accuracies of glycated hemoglobin, fructosamine, and homeostasis model assessment of insulin resistance in predicting impaired fasting glucose, impaired glucose tolerance, or new onset diabetes after transplantation. Transplantation 2015: 292:657–658.Google Scholar
- 15.Xu YS, Huang YQ. Clinical observation of Tangyiping Water Pills in treatment of patients with impaired glucose tolerance and the effect on glucolipid metabolism and inflammatory factors. Chin J Inf Tradit Chin Med (Chin) 2012;19:13–15.Google Scholar
- 16.Trumbo P, Schlincker S, Yates AA, Poos M, Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. J Am Diet Assoc 2002;102:1621–1630.CrossRefPubMedGoogle Scholar
- 17.Zheng XY, ed. Guiding principle of clinical research on new Chinese medicine drugs. Beijing: China Medical Science and Technology Press;2002:233–237.Google Scholar
- 23.Liu C. TRIPOD Research Introduction and review of Liaoning. J Pract Diabetol (Chin) 2004;12:7–9.Google Scholar